Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13D for HilleVax, Inc. Common Stock, par value $0.0001 per share (HLVX).
- Disclosed ownership: 9.8%.
- Date of event: 02 May 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 9.8% ownership in HilleVax, Inc. Common Stock, par value $0.0001 per share (HLVX) on 02 May 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 9.8% | 4,920,000 | 0 | 4,920,000 | /s/ Kevin Tang | Manager | 0001232621 |
| KEVIN TANG | 9.8% | 4,920,000 | 0 | 4,920,000 | /s/ Kevin Tang | Self | 0001178579 |
| TANG CAPITAL PARTNERS, LP | 5.5% | 2,767,008 | 0 | 2,767,008 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0001191935 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 4.3% | 2,152,992 | 0 | 2,152,992 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | 0002064011 |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | |
| CONCENTRA BIOSCIENCES, LLC | 0% | 0 | 0 | 0 | /s/ Kevin Tang | Chief Executive Officer | 0001970065 |